论文部分内容阅读
目的:探究硬膜外阻滞麻醉分娩镇痛母婴安全性。方法:以2010年8月~2012年3月期间进行自然分娩的210例初产妇为研究对象,采用药物分娩镇痛110例为实验组,物理方法止痛100例为对照组。对比分析各组产程时间、产妇生理变化及新生儿Apgar评分等。结果:实验组第一、二产程较对照组明显缩短(P<0.05);实验组产痛Ⅱ级人数远多于对照组,产痛Ⅲ、Ⅳ级产妇少于对照组(P<0.05)。在第一产程活跃期,实验组产妇生理状况更稳定(P<0.05);新生儿Apgar评分无明显差异,表明采用硬膜外阻滞麻醉不会对胎儿产生不利影响。结论:应用硬膜外阻滞麻醉进行分娩镇痛,可大大减轻产妇痛苦,缩短产程,且安全性高,对母婴均有利无害,值得推广应用。
Objective: To investigate the safety of labor and analgesia for mother-infant epidural anesthesia. Methods: A total of 210 primiparae who were delivered spontaneously between August 2010 and March 2012 were enrolled in this study. 110 cases of drug delivery analgesia were used as experimental group, and 100 cases of physical pain as control group. The duration of labor, maternal physiological changes and neonatal Apgar score were compared between groups. Results: The first and second stage of labor in the experimental group were significantly shorter than those in the control group (P <0.05). The number of laborer Ⅱ in the experimental group was much more than that in the control group. The number of pain-relieving women in stage Ⅲ and Ⅳ was less than that in the control group (P <0.05). During the active phase of the first stage of labor, the maternal physiological condition in the experimental group was more stable (P <0.05); there was no significant difference in the Apgar score of the newborn, indicating that epidural anesthesia would not adversely affect the fetus. Conclusion: Epidural anesthesia for labor analgesia can greatly reduce the pain of maternal, shorten the birth process, and high safety, both harmless to maternal and child, it is worth promoting the application.